P01011 (AACT_HUMAN) Homo sapiens (Human)
Alpha-1-antichymotrypsin UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
However, an attempt to improve models for this target was made on 2025-04-29. The outcome - failed for technical reasons.
Available Structures
26 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin without any … |
Heteromer | 97.32 | 1×MLA; | |||
| Infectious B19V capsid |
Heteromer Q6RCN1; | 100.0 | ||||
| Crystal structure of Alpha1-antichymotrypsin variant DBS-I-allo1: an allosterically triggered drug-… | homo-2-mer | 94.97 | 3×EDO; 1×CL; | |||
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex w… | homo-2-mer | 97.05 | 1×HCY; 5×EDO; | |||
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex w… | homo-2-mer | 97.05 | 1×AS4; 1×EDO; | |||
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex w… | homo-2-mer | 97.05 | 1×STR; 2×EDO; | |||
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex w… | homo-2-mer | 97.04 | 1×C0R; | |||
| Crystal structure of Alpha1-antichymotrypsin variant DBS-I-allo2: a MMP9-cleavable drug-binding ser… | homo-2-mer | 95.28 | 1×CIT; 1×EDO; | |||
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex w… | homo-2-mer | 97.04 | 1×TES; | |||
| Crystal structure of Alpha1-antichymotrypsin variant DBS-I5: a MMP14-cleavable drug-binding serpin … | homo-2-mer | 95.82 | 1×PEG; 1×DXT; | |||
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-II: a new binding globulin in complex wi… | homo-2-mer | 97.93 | 2×EDO; 1×HCY; | |||
| Crystal structure of Alpha1-antichymotrypsin variant DBS-II: a drug-binding serpin for doxorubicin | homo-2-mer | 94.97 | 1×DM2; | |||
| Crystal form 2 of Alpha1-antichymotrypsin variant DBS-II-allo: an allosterically modulated drug-bin… | homo-2-mer | 94.64 | 1×CL; 1×EDO; 1×NI; | |||
| CRYSTAL STRUCTURE OF CLEAVED HUMAN ALPHA1-ANTICHYMOTRYPSIN AT 2.7 ANGSTROMS RESOLUTION AND ITS COMP… | homo-2-mer | 100 | 1×NAG; 1×NAG; 1×PO4; | |||
| Crystal structure of Alpha1-antichymotrypsin variant DBS-I1: a drug-binding serpin for doxycycline | homo-2-mer | 95.27 | 1×EDO; 1×DXT; | |||
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-0: a new binding globulin variant that i… | homo-2-mer | 98.81 | ||||
| Crystal structure of Alpha1-antichymotrypsin variant DBS-II-allo-L55V: an allosterically controlled… | homo-2-mer | 94.61 | 4×EDO; | |||
| Crystal form 1 of Alpha1-antichymotrypsin variant DBS-II-allo: an allosterically modulated drug-bin… | homo-2-mer | 94.92 | 3×EDO; 1×DM2; | |||
| CLEAVED ANTICHYMOTRYPSIN A349R | homo-2-mer | 99.7 | 1×ACT; | |||
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III-allo: an allosterically controlled n… | homo-2-mer | 96.97 | 3×CL; 3×CA; 2×EDO; | |||
| CLEAVED ANTICHYMOTRYPSIN A347R | homo-2-mer | 99.7 | ||||
| CLEAVED ANTICHYMOTRYPSIN T345R | homo-2-mer | 99.7 | ||||
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-I in the uncleaved S-conformation | monomer | 96.69 | ||||
| Antichymotrypsin | monomer | 99.72 | ||||
| Infectious B19V capsid | monomer | 100.0 | ||||
| Alpha1-antichymotrypsin serpin in the delta conformation (partial loop insertion) | monomer | 99.73 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3dlw.1.A | monomer | 0.82 | 99.25 | |||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 5om7.1.A | monomer | 0.80 | 98.43 | |||
| Isoform 3 | 9d7k.1.A | monomer | 0.65 | 78.48 | |||